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Abstract
The effects of a compound including the secondary metabolites of garlic, propyl thiosulphinate (PTS) and propyl thiosulphinate oxide
(PTSO), on the in vitro and in vivo parameters of chicken gut immunity during experimental Eimeria acervulina infection were evaluated.
In in vitro assays, the compound comprised of PTSO (67 %) and PTS (33 %) dose-dependently killed invasive E. acervulina sporozoites and
stimulated higher spleen cell proliferation. Broiler chickens continuously fed from hatch with PTSO/PTS compound-supplemented diet
and orally challenged with live E. acervulina oocysts had increased body weight gain, decreased faecal oocyst excretion and greater
E. acervulina profilin antibody responses, compared with chickens fed a non-supplemented diet. Differential gene expression by micro-
array hybridisation identified 1227 transcripts whose levels were significantly altered in the intestinal lymphocytes of PTSO/PTS-fed birds
compared with non-supplemented controls (552 up-regulated, 675 down-regulated). Biological pathway analysis identified the altered
transcripts as belonging to the categories ‘Disease and Disorder’ and ‘Physiological System Development and Function’. In the former cat-
egory, the most significant function identified was ‘Inflammatory Response’, while the most significant function in the latter category was
‘Cardiovascular System Development and Function’. This new information documents the immunologic and genomic changes that occur in
chickens following PTSO/PTS dietary supplementation, which are relevant to protective immunity during avian coccidiosis.
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Garlic (Allium sativum) is a medicinal plant that has histori-
cally been used for the treatment and prevention of some dis-
eases and has recently been shown to have antimicrobial,
antitumour, antioxidant and immunostimulatory proper-
ties(1–4). The pharmacological effects of garlic on cardiovas-
cular disease (CVD) are mediated through the alteration of
cholesterol and triglyceride (TAG) levels in the blood-
stream(5). The medicinal effects of garlic are derived from
its flavonoid and organosulphur components. Studies in
mammalian systems have indicated that these active pharma-
cological components act on multiple intracellular signalling
pathways. In chickens, garlic compounds have also been
shown to lower cholesterol and exert immunomodulating
and antimicrobial activities(6–9). However, compared with
human studies, there is relatively limited information on the
use of phytonutrients in general, and garlic in particular, in
poultry veterinary medicine.
In addition to its effects on the cardiovascular system, garlic
has been suggested for the treatment of parasitoses and other
intestinaldiseases(10). Forexample, crudeextractsofgarlic reduced
or eliminated Hymenolepis, Aspiculuris, Histomonas and Eimeria
parasites in animal models of infection(11–15). Of these parasites,
coccidia protozoa comprise a subclass of single-celled eukaryotic
micro-organisms belonging to the phylum Apicomplexa and
class Conoidasida. Coccidia of the genus Eimeria infect the intesti-
nal epithelia of chickens, turkeys and some mammalian hosts.
The intestinal intraepithelial lymphocytes (IEL), the primary
immune effector cells of the gut-associated lymphoid tissues,
recognise and destroy pathogens that breach the intestinal
epithelium(16). Chicken intestinal IEL are composed of two phe-
notypically and functionally distinct subpopulations, natural-
killer (NK) cells and T-lymphocytes(17). In our previous studies,
we have shown that IEL are the major effectors against coccidia
parasites, Eimeria (18,19). In chickens, disruption of the gut
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epithelium during avian coccidiosis severely restricts the feed
conversion efficiency during commercial poultry production.
While in-feed anticoccidial drugs and antibiotic growth pro-
moters can be used to mitigate some of the effects of avian
coccidiosis, the emergence of drug-resistant parasites and
legislative restrictions on the use of in-feed antibiotic growth
promoters are driving the development of alternative disease
control strategies for poultry production(20,21). Because garlic
has been shown to exert anticoccidial effects in mouse and
rabbit infection models(14), in the present study we evaluated
the effects of a compound including garlic-derived secondary
metabolites, propyl thiosulphinate (PTS) and propyl thiosul-
phinate oxide (PTSO), on intestinal immunity to E. acervulina.
Materials and methods
Parasite cytotoxicity assay
Freshly sporulated E. acervulina oocysts were disrupted with
0·5 mm glass beads for 5–7 s and the freed sporocysts were incu-
bated for 45 min at 418C in PBS containing 0·014 M-
taurodeoxycholic acid (Sigma) and 0·25 % trypsin (Sigma) to
release infective sporozoites. Sporozoites were separated from
debris by filtration, resuspended in Roswell Park Memorial Insti-
tute (RPMI)-1640 medium (Invitrogen), and isolated by centrifu-
gation at 2100 g for 10 min at 48C. Isolated sporozoites
(1·0 £ 106/ml) were incubated with PBS (negative control),
10mg/ml of Garlicon40w or 5·0mg/ml of chicken purified
recombinant NK-lysin (positive control)(22) for 2 or 4 h at 48C,
and viability was measured by trypan blue exclusion by count-
ing a minimum of 100 sporozoites.
Garlicon40w, a product containing 40 % of a compound made
of 67 % of propyl thiosulphinate oxide (PTSO) and 33 % of PTS,
was provided by Pancosma S.A. The biosynthesis of PTS is made
from propiin (S-propyl-L-cysteine sulphoxide), an amino acid
derived from L-cysteine found in Allium species. The first step
of the biosynthesis (of thiosulphinates) is the formation of the
sulphenic acid associated (in this case propyl-1-sulphenic
acid; CH3CH2CH2SOH) plus pyruvate plus ammonia. However,
these compounds (sulphenic acids) are highly reactive, so they
immediately produce thiosulphinates by a condensation reac-
tion. In the last step, heating PTS induces its dismutation in
PTSO and propyldisulphide. Propyldisulphide can be oxidised
and transformed to PTSO and the oxidation of PTS to PTSO is
never totally completed. Therefore, the two molecules are gen-
erally present in commercial samples. Garlicon40wwas notated
as PTSO/PTS in the present study.
Spleen lymphocyte proliferation
All experiments were approved by the Agricultural Research
Service Institutional Animal Care and Use Committee. For the
purpose of the experiment, 3-week-old Ross/Ross broiler
chickens (Longenecker’s Hatchery) were euthanised by
cervical dislocation, and the spleens were removed and
placed in Petri dishes with 10 ml of Hank’s balanced salt
solution (HBSS) supplemented with 100 units/ml penicillin
and 100mg/ml streptomycin (Sigma). Cell suspensions were
prepared by gently flushing through a cell strainer and
lymphocytes were purified by density gradient centrifugation
through Histopaque-1077 (Sigma). The cells were adjusted to
1·0 £ 107 cells/ml in RPMI-1640 medium without phenol red
(Sigma) and supplemented with 10 % fetal bovine serum,
100 units/ml penicillin and 100mg/ml streptomycin. Then,
100ml/well of the sample were added to ninety-six-well flat-bot-
tomed plates containing 100ml/well of PTSO/PTS (10, 5, 2·5,
1·25, 0·6 or 0·3mg/ml) from Pancosma S.A., 5mg/ml of concana-
valin A (Sigma) as a positive control, or medium alone as a nega-
tive control. The cells were incubated at 418C in a humidified
incubator (Forma) with 5 % CO2 for 48 h, and the cell numbers
were measured using WST-8 (2-(2-methoxy-4-nitrophenyl)-3-
(4-nitrophenyl)-5-(2,4-disulphophenyl)-2H-tetrazolium, mono-
sodium salt) (Dojindo Molecular Technologies) at 450 nm using
a microplate spectrophotometer (Bio-Rad).
Experimental animals and diets
Broiler chickens (Ross/Ross, Longenecker’s Hatchery) were
randomly housed in Petersime starter brooder units and fed,
from hatch, a standard diet alone (control) or a diet supple-
mented with 10·0 parts per million of PTSO/PTS. The compo-
sition of the standard diet was prepared as recommended by
the National Research Council(23). The PTSO/PTS dose was
chosen based on preliminary dose–response experiments.
Eimeria acervulina infection of chickens
At 10 d post-hatch, the chickens were transferred to large
hanging cages (two birds/cage) and were orally infected
with 1·0 £ 104 sporulated oocysts of E. acervulina. The
remaining chickens were housed in neighbouring cages,
but were uninfected. Body weights (twenty birds/group)
were measured at 0 and 10 d post-infection. Faecal samples
(twenty birds/group) were collected between 6 and 9 d post-
infection, and oocyst numbers were determined using a
McMaster chamber (HK Inc.) according to the formula(24):
total oocysts/bird ¼ oocyst count £ dilution factor £ (faecal
sample volume/counting chamber volume)/2.
Anti-profilin serum antibody assay
Peripheral blood (four birds/group) was collected from unin-
fected and infected chickens at 10 d post-infection, and sera
were prepared by centrifugation and analysed for anti-profilin
antibody levels by ELISA. For this, ninety-six-well plates were
coated overnight with 10mg/well of E. acervulina purified
recombinant profilin protein as described(25). The plates were
washed with PBS containing 0·05 % Tween and blocked with
PBS containing 1·0 % bovine serum albumin (Sigma). Diluted
sera at 1:50 were added (100ml/well), incubated with agitation
for 1 h at room temperature and washed with PBS containing
0·05 % Tween. Bound antibody was detected with horseradish
peroxidase-conjugated rabbit anti-chicken IgG (Sigma) and
3,30,5,50-tetramethylbenzidine substrate (Sigma) by measuring
the optical density at 450 nm. All samples were analysed in
quadruplicate.
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Microarray hybridisation
Chicken intestinal IEL were isolated from the non-infected chick-
ens at 14d post-hatch as described(26) and gene expression anal-
ysis was performed by microarray hybridisation. The intestinal
jejunum was removed, cut longitudinally and washed three
times with ice-cold HBSS. Then, the samples were incubated in
HBSS containing 0·5mM-EDTA and 5% fetal calf serum for
20minat 378Cwith constant swirling.Cells released into the super-
natant were passed through nylon wool (Robbins Scientific), and
washed twice with HBSS containing 5% fetal calf serum. The
IEL were purified by Percoll density gradient centrifugation and
washed three times with HBSS containing 5% fetal calf serum.
In preliminary experiments, we determined that the percen-
tage of CD45-positive IEL ranges from 45 to 70% depending
upon the genetics, age and infection status of chickens used
(data not shown). Total RNA (six birds/group) was isolated
using Trizol (Invitrogen) and pooled in two samples with equal
amount from three birds each. RNA were amplified using
the Two-Color Quick Amp Labeling Kit (Agilent Technologies)
with cyanine 3 (Cy3)- or Cy5-labelled CTP. The RNA probes
from the control and treatment groups labelled with two different
colours were hybridised with one Chicken Gene Expression
Microarray (Agilent Technologies) containing 43 803 elements.
Then, two biological replicates were conducted with alternation
of Cy3- and Cy5-labelled RNA to prevent data distortion
from sample labelling(27). Microarray images were scanned, and
data extraction and analysis were performed using Feature
Extraction software version 10.7.3.1 (Agilent Technologies).
Microarray data analysis
GeneSpring GX10 software (Silicon Genetics) was used to qua-
lify and normalise image analysis data and to determine the fold
changes in gene expression. Average signal intensities were cor-
rected for background signals and normalised by the locally
weighted regression and smoothing scatter plots method. Flag
information was applied to strain the spots with 100 % valid
values from each sample and an asymptotic t test analysis was
performed to analyse the significance between PTSO/PTS-fed
and non-supplemented control groups. To generate signal
ratios, signal channel values from PTSO/PTS-fed birds were
divided by values from negative controls. Modulated elements
were defined as RNA with .2·0-fold increased or decreased
levelswith P,0·05, as determinedby the Student’s t test. Thedif-
ferentially expressed genes were filtered using the Volcano Plot
method(28) built by the t test. Allmicroarray information anddata
were deposited in the Gene Expression Omnibus database
(series record no. GSE36302).
Quantitative RT-PCR
Gene expression changes observed by microarray analysis
were confirmed by quantitative RT-PCR as described(29).
Equivalent amounts of the same RNA samples used for
microarray hybridisations were reverse-transcribed using
the StrataScript First Strand Synthesis System (Stratagene).
Oligonucleotide primers are listed in Table 1. Amplification T
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and detection were carried out using the Mx3000P system and
Brilliant SYBR Green quantitative RT-PCR master mix
(SABioscience, Stratagene). Standard curves were generated
using log10 diluted standard RNA and the levels of individual
transcripts were normalised to those of glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) by the Q-gene
program(30). For the calculation of fold changes between treat-
ment groups, the cycle threshold (Ct) value of the target gene
was normalised to GAPDH and calibrated to the relevant
control value. Each analysis was performed in triplicate.
Bioinformatics data analysis
Differentially expressed genes between the PTSO/PTS-fed and
control chickens were analysed using Ingenuity Pathway Anal-
ysis software (IPA) (Ingenuity Systems). Each identifier was
mapped to its corresponding gene in IPA (Ingenuity Systems).
Both 2·0-fold increased and 2·0-fold decreased identifiers were
defined as value parameters for the analysis. These genes,
termed ‘focus genes’, were superimposed onto the global mol-
ecular networks contained within IPA (Ingenuity Systems).
Functional gene analysis was performed to identify the
biological functions and canonical pathways of genes from
the mapped data sets. The Fisher’s exact test was used to cal-
culate P values to assess the probability of each biological
function and pathway assigned to that data set. The pathways
of focus genes were algorithmically generated based on their
connectivity.
Statistical analysis
Data from parasite cytotoxicity assays, body weight gains,
oocyst shedding, spleen lymphoproliferation and profilin
antibody levels were expressed as the mean and standard
deviation values. Comparisons of the mean values were
performed by one-way ANOVA followed by Duncan’s
multiple-range test or Student’s t test using SPSS software
(SPSS 15.0 for Windows); differences between groups were
considered statistically significant at P,0·05.
Results
Effect of dietary propyl thiosulphinate oxide/propyl
thiosulphinate on in vitro sporozoite viability and spleen
cell proliferation
Treatment of freshly prepared E. acervulina sporozoites with
10mg/ml of PTSO/PTS for 2 or 4 h significantly decreased
parasite viability by 18 and 71 %, respectively (Fig. 1A). The
reduced sporozoite viability was comparable with that pro-
duced by 5·0mg/ml of chicken purified recombinant NK
lysin, previously shown to be cytotoxic for E. acervulina
and E. maxima parasites(22).
PTSO/PTS significantly increased splenocyte proliferation
at 2·5mg/ml or higher concentrations tested compared with
the medium control at P,0·001 (Fig. 1B).
Effect of dietary propyl thiosulphinate oxide/propyl
thiosulphinate on body weight gain and faecal oocyst
excretion following experimental Eimeria acervulina
infection
Dietary supplementation with PTSO/PTS significantly increased
body weight gain in E. acervulina-infected chickens compared
with infected birds given a non-supplemented control diet
(Fig. 2A). In addition, chickens fed a diet supplemented
with PTSO/PTS showed decreased faecal oocyst excretion
compared with non-supplemented controls (Fig. 2B).
Effect of dietary propyl thiosulphinate oxide/propyl
thiosulphinate on serum anti-profilin antibody levels
Serum antibody levels against E. acervulina profilin were
measured as a parameter of humoral immunity in PTSO/PTS-
supplemented and non-supplemented chickens. The profilin
antibody levels were higher in Eimeria-infected chickens than
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Fig. 1. Effect of propyl thiosulphinate oxide/propyl thiosulphinate
(PTSO/PTS) in vitro. (A) Eimeria acervulina (EA) sporozoites (1·0 £ 106/ml)
were incubated with PBS (control), 10mg/ml of PTSO/PTS or 5·0mg/ml of
chicken recombinant natural killer (NK) lysin, for 2 or 4 h at 48C, and viability
was measured by trypan blue exclusion by counting a minimum of 100 spor-
ozoites. (B) Spleen cells were treated with the indicated concentrations of
PTSO/PTS, concanavalin A (Con A; 5mg/ml) or medium (control) for 48 h
and viable cell numbers were measured using 2-(2-methoxy-4-nitrophenyl)-3-
(4-nitrophenyl)-5-(2,4-disulphophenyl)-2H-tetrazolium. Values are means,
with standard deviations represented by vertical bars (n 3). Mean values
were significantly different from those of PTSO/PTS-treated with control
groups according to the Student’s t test: * P,0·05; *** P,0·001. OD, optical
density.
Efficacy of garlic metabolites in poultry 79
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114512000530
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 10 Jul 2017 at 15:40:05, subject to the Cambridge Core terms of use, available at
in the uninfected control at 10 d post-infection, and dietary
PTSO/PTS significantly (P,0·05) increased serum profilin anti-
body levels (Fig. 3) compared with non-supplemented controls.
Effect of dietary propyl thiosulphinate oxide/propyl
thiosulphinate on differential gene expression
Microarray hybridisation analysis using Agilent Technologies’
Chicken Gene Expression Microarray which contains 43 803
elements identified 1227 mRNA whose levels were altered
.2·0-fold in intestinal IEL of PTSO/PTS-treated chickens com-
pared with non-supplemented controls. Of these, 552 were
increased and 675 were decreased. This data set was mapped
to the corresponding genes of the human, mouse and rat
genome using Ingenuity Knowledge Base software (Ingenuity
Systems), and 288 chicken genes were identified and anno-
tated. Tables 2 and 3 list the genes corresponding to the
twenty most up- or down-regulated transcripts, respectively.
Quantitative RT-PCR validation
The expression patterns observed by microarray analysis were
validated by quantitative RT-PCR with four selected transcripts
whose levels were significantly modulated between PTSO/
PTS-fed and non-treated chickens. These genes were adipo-
nectin receptor 2, aspartate b-hydroxylase, IL-8 and TNF
(ligand) superfamily member 13b (TNFSF13B). The levels of
these transcripts that were up- or down-regulated by micro-
array hybridisation were also correspondingly altered when
analysed by quantitative RT-PCR (Fig. 4). As previously
discussed, the differences in the magnitude between the
changes observed, particularly with adiponectin receptor 2
and aspartate b-hydroxylase, might be due to differences in
the normalisation methods and/or the different fluorescent
dyes used in the two techniques(31).
Biological function and pathway analyses
Biological function analysis using the IPA (Ingenuity Systems)
database was performed for the 288 genes corresponding to
the mRNA that were differently altered following dietary
PTSO/PTS treatment compared with untreated controls. The
P value associated with a particular function in this analysis
is a statistical measure of the likelihood that genes from the
data set under investigation participate in that function. In
this manner, these genes were classified under the categories
‘Disease and Disorders’ and ‘Physiological System Development
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Fig. 3. Effect of dietary propyl thiosulphinate oxide/propyl thiosulphinate
(PTSO/PTS) on profilin antibody (Ab) levels. Chickens were fed from hatch
with non-supplemented (control) or PTSO/PTS-supplemented diets and
orally infected with 1·0 £ 104 oocysts of Eimeria acervulina at 10 d post-
hatch. Peripheral blood (four birds/group) was collected at 10 d post-infection
and sera were analysed for anti-profilin Ab levels by ELISA. Values are
means, with standard deviations represented by vertical bars (n 4). a,b,c Mean
values with unlike letters are significantly different according to Duncan’s
multiple-range test (P,0·05). OD, optical density.
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Fig. 2. Effect of dietary propyl thiosulphinate oxide/propyl thiosulphinate
(PTSO/PTS) on body weight gain and faecal oocyst excretion following
experimental Eimeria acervulina infection. Chickens were fed from hatch with
non-supplemented or PTSO/PTS-supplemented diets and either uninfected
or orally infected with 1·0 £ 104 oocysts of E. acervulina at 10 d post-hatch.
(A) Body weights (twenty birds/group) were measured in non-infected and
infected chickens on the non-supplemented diet (control), and in infected
chickens on the PTSO/PTS-supplemented diet at 0 and 10 d post-infection.
Values are means, with standard deviations represented by vertical bars.
a,b Mean values with unlike letters were significantly different according to
Duncan’s multiple-range test (P,0·05). (B) Faecal samples (twenty bird-
s/group) were collected from chickens on the non-supplemented (control)
and PTSO/PTS-supplemented diets between 6 and 9 d post-infection and
total oocyst numbers were determined using a McMaster chamber. Values
are means, with standard deviations represented by vertical bars. ** Mean
value was significantly different from that of the control group (P,0·01;
Students t test).
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Table 3. Genes corresponding to down-regulated intestinal intraepithelial lymphocyte transcripts in chickens given a propyl thiosulphinate oxide/propyl thiosulphinate-supplemented diet compared
with a non-supplemented diet
Symbol Entrez gene name Agilent no. Fold change Location Function
UCP3 Uncoupling protein 3 (mitochondrial, proton carrier) A_87_P037720 0·063 Cytoplasm Transporter
F2RL2 Coagulation factor II (thrombin) receptor-like 2 A_87_P021894 0·088 Plasma membrane G-protein coupled receptor
FCN2 Ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) A_87_P012535 0·102 Extracellular space Other
LAMB2 Laminin, beta 2 (laminin S) A_87_P037980 0·127 Extracellular space Enzyme
C1ORF63 Chromosome 1 open reading frame 63 A_87_P023430 0·143 Unknown Other
NUF2 NUF2, NDC80 kinetochore complex component, homologue (S. cerevisiae) A_87_P036083 0·154 Nucleus Other
FREM1 FRAS1 related extracellular matrix 1 A_87_P029906 0·154 Extracellular space Other
C5ORF34 Chromosome 5 open reading frame 34 A_87_P016635 0·165 Unknown Other
TLR5 Toll-like receptor 5 A_87_P018174 0·171 Plasma membrane Transmembrane receptor
HMGCS2 3-Hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) A_87_P031965 0·171 Cytoplasm Enzyme
MTMR7 Myotubularin related protein 7 A_87_P011372 0·176 Cytoplasm Phosphatase
PDCD2L Programmed cell death 2-like A_87_P036130 0·190 Unknown Other
C21ORF7 Chromosome 21 open reading frame 7 A_87_P023657 0·191 Unknown Other
SCN2A Sodium channel, voltage-gated, type II, a subunit A_87_P015799 0·194 Plasma membrane Ion channel
C8ORF4 Chromosome 8 open reading frame 4 A_87_P024345 0·196 Unknown Other
C13ORF27 Chromosome 13 open reading frame 27 A_87_P021548 0·203 Unknown Other
WDR47 WD repeat domain 47 A_87_P034462 0·203 Unknown Other
ERI1 Exoribonuclease 1 A_87_P036756 0·203 Unknown Enzyme
PNLIP Pancreatic lipase A_87_P023861 0·211 Extracellular space Enzyme
CREBL2 cAMP responsive element binding protein-like 2 A_87_P021605 0·212 Nucleus Transcription regulator
Table 2. Genes corresponding to up-regulated intestinal intraepithelial lymphocyte transcripts in chickens given a propyl thiosulphinate oxide/propyl thiosulphinate-supplemented diet compared with a
non-supplemented diet
Symbol Entrez gene name Agilent no. Fold change Location Function
PDPR Pyruvate dehydrogenase phosphatase regulatory subunit A_87_P008075 69·47 Unknown Enzyme
ITGB1BP2 Integrin beta 1 binding protein (melusin) 2 A_87_P024694 46·814 Unknown Other
SH3BP4 SH3-domain binding protein 4 A_87_P007874 38·585 Unknown Other
CRH Corticotropin-releasing hormone A_87_P037220 32·849 Extracellular space Other
SDK2 Sidekick homologue 2 (chicken) A_87_P037566 23·605 Unknown Other
MDK Midkine (neurite growth-promoting factor 2) A_87_P009319 23·142 Extracellular space Growth factor
C6ORF167 Chromosome 6 open reading frame 167 A_87_P037304 21·443 Unknown Other
TMEM213 Transmembrane protein 213 A_87_P021765 20·831 Unknown Other
C9ORF24 Chromosome 9 open reading frame 24 A_87_P020203 17·712 Unknown Other
HBE1 Hb, epsilon 1 A_87_P032051 16·162 Cytoplasm Transporter
TRRAP Transformation/transcription domain-associated protein A_87_P000649 14·944 Nucleus Transcription regulator
CBX6-NPTXR Cbx6-Nptxr readthrough transcripts A_87_P040723 12·795 Unknown Other
MACF1 Microtubule-actin crosslinking factor 1 A_87_P011329 12·455 Cytoplasm Other
AGXT2L1 Ala-glyoxylate aminotransferase 2-like 1 A_87_P016602 12·318 Unknown Enzyme
CDON Cdon homologue (mouse) A_87_P015827 11·982 Plasma membrane Other
VAX1 Ventral anterior homeobox 1 A_87_P038172 11·949 Nucleus Transcription regulator
VTN Vitronectin A_87_P008745 11·378 Extracellular space Other
ARC Activity-regulated cytoskeleton-associated protein A_87_P037475 11·005 Cytoplasm Other
POMC Pro-opiomelanocortin A_87_P009245 10·626 Extracellular space Other
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and Function’. In the category ‘Disease and Disorders’, the
most significant function that was identified was ‘Inflammatory
Response’ (Table 4). In the category ‘Physiological System
Development and Function’, the most significant function
that was identified was ‘Cardiovascular System Development
and Function’ (Table 5). Canonical Pathway analysis classified
the genes whose expressions were significantly modified by
PTSO/PTS dietary supplementation to eight selected biological
functions (Table 6). Of these, the pathway of ‘Communication
Between Innate and Adaptive Immune Cells’ was identified as
the most significant pathway and included five genes. Overall,
seventeen groups of pathway networks, classified according
to the number of focus genes, are listed in Table 7. Fig. 5 illus-
trates the most significant network converging on the NF-kB
transcription factor with twenty-four focus genes identified.
Discussion
The present study was conducted to investigate the immuno-
logic and genomic alterations following dietary supplemen-
tation with PTSO/PTS, the secondary metabolites of garlic,
during E. acervulina infection of chickens.
PTSO/PTS enhanced the in vitro and in vivo parameters of
immunity. Treatment of chicken spleen cells with PTSO/PTS
increased their proliferation and treatment of E. acervulina
sporozoites with PTSO/PTS decreased cell viability. Chickens
given a PTSO/PTS-supplemented diet and infected with
E. acervulina had greater body weight gain, reduced faecal
oocyst excretion and increased profilin antibody responses
compared with chickens fed a non-supplemented diet. Some
of these responses may have been due to a direct cytotoxic
effect of PTSO/PTS on parasite sporozoites. Microarray
hybridisation identified 1227 transcripts whose levels were
significantly altered in the intestinal IEL of PTSO/PTS-fed
birds compared with non-supplemented controls. Biological
pathway analysis identified the altered transcripts as belonging
to the categories ‘Disease and Disorder’ and ‘Physiological
System Development and Function’.
Garlic has been traditionally used as a folk remedy to treat a
variety of human diseases, the health-promoting effects of
which are attributed to the presence of multiple sulphur-
containing compounds, such as diallyl sulphide, diallyl disul-
phide, dipropyl sulphide and allicin. These compounds, and
others, have demonstrated pharmacological activity in vitro
and in vivo (32–35). Allicin is generally considered to be one
of the primary active compounds that gives garlic its character-
istic odour and many of its healing benefits. Thiacremonone,
a novel sulphur compound isolated from garlic, possesses
anti-inflammatory properties through the inhibition of NF-kB
activation in rats and mice(36). NF-kB is a major transcription
factor that plays a key role in regulating the immune response
to infection following the binding of pathogenic micro-
organisms to a variety of cell surface receptors, such as Toll-
like receptors (TLR)(37). Our bioinformatic analysis identified
NF-kB as a central molecule in the most significant network
that was activated in PTSO/PTS-treated chickens. This net-
work also included TLR3 and TLR5 as down-regulated com-
ponents. Further evidence for the modulation of TLR and
NF-kB in response to garlic comes from the study of Youn
et al.(38) showing that the ethyl acetate fraction of the
plant bulb inhibited lipopolysaccharide-induced dimerisation
of TLR4 and blocked NF-kB activation.
Interestingly, however, our functional studies indicated that
dietary PTSO/PTS increased the resistance of chickens to
experimental E. acervulina infection, as evidenced by greater
weight gain and reduced parasite excretion, and augmented
parameters of adaptive immunity, including a higher profilin
antibody response and greater spleen cell proliferation, com-
pared with chickens fed a non-supplemented diet. The ability
of PTSO/PTS to directly kill sporozoites and stimulate spleen
cell proliferation in vitro suggests that a similar mechanism
may operate in vivo, thus contributing to increased body
weight and decreased parasite fecundity.
The capability of the PTSO/PTS preparation to stimulate
spleen cell mitogenesis (an indicator of adaptive cellular
immunity), while simultaneously down-regulating TLR and
NF-kB (indicators of innate immunity), suggests that the diet-
ary supplement may have more than one active component.
In this regard, Clement et al.(39) identified several immuno-
modulatory proteins from garlic with mitogenic activity
towards human peripheral blood lymphocytes and murine
splenocytes. Further studies to characterise the active com-
ponents of garlic and their effects on innate and adaptive
immunity will help to resolve these questions.
In the biological functional analysis, eighteen genes were
related with the most reliable ‘Inflammatory Response’ category
(Table 4). Among those genes, TLR are a major component of
the pattern recognition receptor repertoire that detect invading
micro-organisms and direct the vertebrate immune system to
eliminate infection. TLR5 plays a role in restricting the entry
of flagellated Salmonella into systemic sites(40) and TLR3
which recognises double-stranded RNA analogue, induces
interferon-b through the recognition of viral double-stranded
RNA in chicken(41). In the present study, TLR3 and TLR5
expression was down-regulated in the bioinfomatical analysis
and this may explain the reduced inflammatory response
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Fig. 4. Comparison between microarray ( ) analysis and quantitative
RT-PCR ( ) for the levels of mRNA corresponding to selected genes. Each
bar represents fold changes of mRNA levels in propyl thiosulphinate oxide/
propyl thiosulphinate-fed chickens compared with non-supplemented con-
trols. ADIPOR2, adiponectin receptor 2; ASPH, aspartate b-hydroxylase;
TNFSF13B, TNF (ligand) superfamily, member 13b.
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Table 4. Significant functions in the category ‘Disease and Disorders’ in chickens given a propyl thiosulphinate oxide/propyl thiosulphinate-supplemented diet compared with a non-supplemented diet
Category* P † Genes
Inflammatory response 2·30£1023–4·24 £ 1022 UNC13D, IL8, VCAM1, VTN, CRH, POMC, JAK2, RNASEL, SELP, TLR5, KL, PLCG2, MDK, HPGDS, TLR3, ADIPOR2,
TFPI, TNFSF13B
Dermatological diseases and conditions 4·11 £ 1023–3·75 £ 1022 IL8, SELP, KL, HBEGF, TNFRSF8, DSP
Endocrine system disorders 4·11 £ 1023–4·11 £ 1023 UBR1, CCKBR
Inflammatory disease 4·11 £ 1023–3·75 £ 1022 IL8, VCAM1, SELP, TLR5, ICA1, PDE5A, HBEGF, TLR3, TNFRSF8, TNPO3, TNFSF13B
Organismal injury and abnormalities 4·11 £ 1023–4·75 £ 1022 SOCS3, IL8, F2RL2, SELP, VTN, UBR1, CRH, PDE5A, HBEGF, MDK, HPGDS, CCKBR
Renal and urological disease 4·11 £ 1023–3·75 £ 1022 VCAM1, SELP, PDE5A, HBEGF, TLR3, MDK, TNFSF13B, ZNF365
Genetic disorder 8·01 £ 1023–3·75 £ 1022 SLC4A4, HCRT, SGCE, DNAJC19, CACNB4, CRH, CACNA1H, POMC, JAK2, HMGCS2, CEP290, MAOB, TLR5, LGI1,
ATCAY, DSP, ATN1, ZNF365
Infection mechanism 8·01 £ 1023–4·24 £ 1022 IL8, TLR5, PLCG2, CD93, TLR3
Infectious disease 8·01 £ 1023–4·24 £ 1022 IL8, TLR5, PLCG2, CD93, TLR3
Metabolic disease 8·01 £ 1023–4·91 £ 1022 SOCS3, PLIN1, ICA1, DNAJC19, CRH, HBEGF, POMC, HMGCS2, LAMB2, SCP2, TLR3, ADIPOR2, CCKBR, ZNF365
Neurological disease 8·01 £ 1023–3·75 £ 1022 CA3, SCN2A, MAOB, HCRT, SGCE, ABCC5, LGI1, CACNB4, CACNA1H, ATCAY, HPGDS, ATN1
Nutritional disease 1·14 £ 1022–4·75 £ 1022 UCP3, HCRT, POMC, CCKBR
Psychological disorders 1·14 £ 1022–4·75 £ 1022 UCP3, HCRT, POMC, CCKBR
Gastrointestinal disease 1·14 £ 1022–4·00 £ 1022 SOCS3, CTRC, PIAS2, DNMT3A, CUBN, LRRC1, HLA-DRB1, SYNE1, TUFT1, KLHL20, NSF, CA3, KIF9, KCTD20, LNPEP,
UBXN4, EFNA5, HPGD, TNFSF15, RERE, ASPH, TLR3, FABP3, CCKBR, IL8, JAZF1, ICA1, SEC16A, MEF2A, MYPN,
TPD52, ITPR1, NFASC, REV3L, FREM1, SH3BP5, HOPX, SELP, EDEM2, TLR5, SCP2, REEP3, PDE5A, TRANK1,
ZNF365
Hepatic system disease 1·14 £ 1022–3·75 £ 1022 JAZF1, CUBN, EFNA5, TUFT1, MYPN, ITPR1, REV3L, TLR3
Connective tissue disorders 1·15 £ 1022–2·60 £ 1022 VCAM1, PLIN1, SELP, TLR5, ICA1, TNPO3, TNFSF13B, CCKBR
Immunological disease 1·15 £ 1022–1·15 £ 1022 VCAM1, SELP, TLR5, ICA1, TNPO3, TNFSF13B
Skeletal and muscular disorders 1·15 £ 1022–3·75 £ 1022 VCAM1, SELP, TLR5, ICA1, MEF2A, TNPO3, TNFSF13B
CVD 1·30 £ 1022–3·75 £ 1022 F2RL2, VCAM1, VTN, TFPI, DSP
Haematological disease 1·30 £ 1022–4·75 £ 1022 SOCS3, IL8, F2RL2, SELP, SCP2, POMC, JAK2, TFPI
Antimicrobial response 2·60 £ 1022–3·75 £ 1022 NCOR1, TLR3, RNASEL
Developmental disorder 2·60 £ 1022–3·75 £ 1022 CEP290, PLIN1, REV3L, ASPH, TLR3, DSP, CCKBR
Cancer 3·38 £ 1022–3·75 £ 1022 DDX5, LMO4, KL, HBEGF, JAK2, ASPH
Hypersensitivity response 3·38 £ 1022–4·24 £ 1022 IL8, VCAM1, SELP, TLR3
Respiratory disease 3·75 £ 1022–3·75 £ 1022 TLR5, PDE5A
* Data sets were analysed by BioFunction analysis using Ingenuity Pathway Analysis software (Ingenuity Systems).
† P-value ranges of the biological functions included in the category. P values were calculated using the right-tailed Fisher’s exact test.
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Table 5. Significant functions in the category ‘Physiological System Development and Function’ in chickens given a propyl thiosulphinate oxide/propyl thiosulphinate-supplemented diet compared with
a non-supplemented diet
Category* P † Genes
Cardiovascular system development and
function
1·21£1024–4·86 £ 1022 IL8, VCAM1, GEM, VTN, MEF2A, ANGPTL2, CRH, POMC, DICER1, JAK2, KLHL20, MLL, SELP, TNFSF15, MDK, ASPH,
TFPI
Nervous system development and
function
9·61 £ 1024–4·22 £ 1022 F2RL2, VAX1, VCAM1, HCRT, GEM, LMO4, CACNA1H, CRH, DLX1, POMC, JAK2, BCL11B, LAMB2, SELP, EFNA5,
CDON, HPGDS, TLR3
Embryonic development 1·40 £ 1023–3·75 £ 1022 SOCS3, VAX1, VCAM1, CTCF, GDF3, KL, MYST3, SEMA6D, HBEGF, GREM1, TRRAP, MLL
Behaviour 1·64 £ 1023–4·24 £ 1022 HCRT, SLC16A2, CRH, POMC
Haematological system development and
function
1·99 £ 1023–4·75 £ 1022 IL8, SOCS3, VCAM1, VTN, CDK6, CRH, HLA-DRB1, POMC, JAK2, MLL, KCNK5, TLR5, SELP, MYST3, TNFSF15,
TNFRSF8, TLR3, WASF2, MDK, TNFSF13B
Haematopoiesis 1·99 £ 1023–4·44 £ 1022 SOCS3, IL8, VCAM1, SELP, MYST3, CDK6, CRH, POMC, JAK2, MLL, TNFSF13B
Organismal development 1·99 £ 1023–4·94 £ 1022 SOCS3, IL8, VCAM1, PLIN1, GDF3, CDK6, CRH, UBR1, POMC, JAK2, MLL, KLHL20, LAMB2, KCNK5, UCP3, MAOB,
SELP, MYST3, TLR3
Immune cell trafficking 2·30 £ 1023–4·44 £ 1022 IL8, VCAM1, TLR5, SELP, VTN, CRH, POMC, TLR3, MDK, JAK2, TNFSF13B
Tissue development 2·30 £ 1023–4·75 £ 1022 IL8, SOCS3, VAX1, VCAM1, GDF3, VTN, UBR1, GREM1, POMC, NFASC, JAK2, SELP, KL, TLR3, TFPI, PRKD1,
TNFSF13B
Connective tissue development and
function
4·11 £ 1023–3·75 £ 1022 VCAM1, UCP3, PLIN1, KL, UBR1, CRH, POMC
Tissue morphology 4·11 £ 1023–4·75 £ 1022 SOCS3, VCAM1, PLIN1, LMO4, VTN, CRH, UBR1, POMC, UCP3, SELP, KL, TNFSF13B, CCKBR
Cell-mediated immune response 6·90 £ 1023–3·75 £ 1022 SOCS3, IL8, VCAM1, SELP, TNFSF13B
Endocrine system development and
function
8·01 £ 1023–4·24 £ 1022 DBI, COMT, CRH, POMC, CCKBR
Organ morphology 8·01 £ 1023–3·75 £ 1022 VCAM1, SELP, MEF2A (includes EG:4205), CRH, HBEGF, POMC, DICER1, TNFSF13B, CCKBR
Organismal functions 8·01 £ 1023–3·75 £ 1022 IL8, MAOB, HCRT, COMT, CRH
Skeletal and muscular system
development and function
1·30 £ 1022–3·75 £ 1022 LAMB2, SOCS3, HOPX, PLIN1, LMO4, KL, VTN, CDON, MDK, MYOG, TFPI, BARX2
Lymphoid tissue structure and
development
1·32 £ 1022–3·75 £ 1022 IL8, SELP, VTN, MDK, TFPI, TNFSF13B
Reproductive system development and
function
1·32 £ 1022–4·24 £ 1022 SOCS3, NSF, VCAM1, GNPDA1, LNPEP, COMT, CRH, HPGD, HBEGF
Digestive system development and
function
1·91 £ 1022–3·75 £ 1022 HCRT, CRH, CCKBR
Organ development 3·38 £ 1022–3·75 £ 1022 SOCS3, IL8, VAX1, SELP, CRH, POMC
Auditory and vestibular system
development and function
3·75 £ 1022–3·75 £ 1022 IL8
Hair and skin development
and function
3·75 £ 1022–4·24 £ 1022 IL8, CTCF, ABCC5, POMC, JAK2, DSP
Humoral immune response 3·75 £ 1022–3·75 £ 1022 TNFSF13B
Organismal survival 3·75 £ 1022–3·75 £ 1022 TLR3
Renal and urological system
development and function
3·75 £ 1022–3·75 £ 1022 KCNK5, GEM, CTCF, CDK6, GREM1
Respiratory system development and
function
3·75 £ 1022–3·75 £ 1022 GREM1, DICER1
Tumour morphology 3·75 £ 1022–4·75 £ 1022 SOCS3, VCAM1, VTN, NFASC, TFPI
* Data sets were analysed by BioFunction analysis using Ingenuity Pathway Analysis software (Ingenuity Systems).
† P-value ranges of the biological functions included in the category. P values were calculated using the right-tailed Fisher’s exact test.
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Table 6. Significant canonical pathways in chickens given a propyl thiosulphinate oxide/propyl thiosulphinate-supplemented diet compared with a non-supplemented diet
Canonical pathway* P† Ratio‡ Focus genes
Communication between innate and adaptive immune cells 1·38£1023 4·67 £ 1022 IL-8, TLR5, HLA-DRB1, TLR3, TNFSF13B
Corticotropin-releasing hormone signalling 2·04 £ 1023 5·88 £ 1022 PLCG2, GNAI1, CRH, MEF2A (includes EG:4205), POMC, ITPR1, ADCY7, PRKD1
TREM1 signalling 4·07 £ 1023 7·25 £ 1022 IL-8, TLR5, PLCG2, JAK2, TLR3
a-Adrenergic signalling 9·55 £ 1023 5·66 £ 1022 PHKB, PLCG2, GNAI1, ITPR1, ADCY7, PRKD1
Altered T-cell and B-cell signalling in rheumatoid arthritis 1·95 £ 1022 4·40 £ 1022 TLR5, HLA-DRB1, TLR3, TNFSF13B
Glutathione metabolism 2·45 £ 1022 4·08 £ 1022 GSTT1, LNPEP, ACSS2, HPGDS
Cyanoamino acid metabolism 2·63 £ 1022 3·12 £ 1022 KL, ACSS2
Leptin signalling in obesity 3·80 £ 1022 5·95 £ 1022 SOCS3, PLCG2, POMC, JAK2, ADCY7
TREM1, triggering receptor expressed on myeloid cells 1.
* Data sets were analysed by Bio Function analysis using Ingenuity Pathway Analysis software (Ingenuity Systems).
† P values were calculated using the right-tailed Fisher’s exact test.
‡ The ratio of the number of genes from the data set that map to the pathway divided by the total number of genes that map to the canonical pathway.
Table 7. Significant networks in chickens given a propyl thiosulphinate oxide/propyl thiosulphinate-supplemented diet compared with a non-supplemented diet
ID Associated network functions No. of focus genes Score
1 Cellular compromise, cell-to-cell signalling and interaction, cellular growth and proliferation 24 38
2 Cardiovascular system development and function, lipid metabolism, small-molecule biochemistry 21 32
3 Connective tissue development and function, embryonic development, skeletal and muscular system development and function 19 29
4 Cell morphology, cellular development, cellular movement 21 28
5 Cardiovascular system development and function, cell morphology, cellular development 19 28
6 Carbohydrate metabolism, small-molecule biochemistry, lipid metabolism 17 24
7 Endocrine system development and function, nervous system development and function, tissue morphology 16 21
8 Lipid metabolism, small-molecule biochemistry, amino acid metabolism 15 20
9 Free-radical scavenging, genetic disorder, metabolic disease 14 19
10 Cell signalling, nucleic acid metabolism, small-molecule biochemistry 14 19
11 Gene expression, cellular compromise, connective tissue disorders 13 17
12 Cell cycle, cellular development, gene expression 13 16
13 Organismal functions, haematological system development and function, tissue morphology 12 15
14 Cardiovascular system development and function, molecular transport, small-molecule biochemistry 12 15
15 DNA replication, recombination, and repair, energy production, nucleic acid metabolism 12 15
16 Molecular transport, small-molecule biochemistry, cell-to-cell signalling and interaction 12 15
17 Cell cycle, DNA replication, recombination, and repair, cellular growth and proliferation 12 14
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seen at the later phase of coccidiosis infection. Although the
underlying mechanisms are not yet known, it was found that
garlic increases NK cell activity and T cell proliferation in
mice(42). Aged garlic extract treatment enhanced NK cell
activity(43,44) and phagocytosis(5). The balance of T helper 1/T
helper 2-type cytokines, such as the secretion of interferon-g
and IL-2 v. IL-4 and IL-10, was regulated by the consumption
of garlic products in a dose-dependent manner(45–47). In chick-
ens, IEL contains two major phenotypically and functionally
distinct populations, NK and T cells, and these cells play
important roles in avian coccidiosis(17). Therefore, it is possible
that dietary garlic enhanced disease resistance against coccidio-
sis by activating these effector cells and enhancing the secretion
of immunomodulating cytokines in the gut. The TNF family is
an important regulator of inflammation, immune responses
and tissue homeostasis(48). TNFSF13B, also known as B-cell
activating factor (B-cell activating factor of the TNF family),
plays a major role in B-cell survival, proliferation and differen-
tiation. TNFSF13B induced the selective expansion of B cells in
the spleen and caecal tonsils when administered to young
chicks(49). The level of TNFSF13B was shown to increase
during various diseases that may reflect the severity of disease
in malaria, virus infection and multiple sclerosis(50–52). How-
ever, the overexpression of TNFSF13B is also involved in
some autoimmune conditions(53,54). In the present study, diet-
ary feeding of normal chickens with PTSO/PTS enhanced
serum antibody response to E. acervulina infection in
Eimeria-infected chickens when antibodies were measured at
10 d after infection. However, for gene expression analysis,
we used uninfected gut tissues from chickens treated with
PTSO/PTS, and we saw the decreased TNFSF13B transcript
compared to the chickens that were not fed with PTSO/PTS.
Therefore, we speculate that the expression of TNFSF13B
may have increased upon coccidiosis infection and this may
have caused high antibody response. Chicken IL-8 (IL-8/
CXCLi2) was the first chicken CXC chemokine identified and
significantly triggered by the exposure of the gut to feed and
bacteria in newly hatched chicks(55). IL-8 has both chemotactic
and angiogenic functions in the chicken(56); so this gene was
also identified in the ‘Cardiovascular System Development
TFPI
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Fig. 5. The most significant network with the indicated genes corresponding to mRNA exhibiting .2·0-fold up- and down-regulated levels following dietary sup-
plementation of propyl thiosulphinate oxide/propyl thiosulphinate compared with non-supplemented controls. Genes corresponding to increased and decreased
mRNA are indicated by red and green colours, respectively, with the colour intensity indicating the relative expression levels. Overlaid numbers are the fold
changes associated with each gene. , Complex; , cytokine/growth factor; , enzyme; , group/complex/other; , transcription regulator; , transmembrane
receptor; , transporter; , unknown; , direct relationship; --, indirect relationship.
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and Function’ category (Table 5). At low concentrations, IL-8 is
chemotactic for monocyte/macrophages and lymphocytes.
However, at high concentrations, IL-8 stimulates sprouting
and growth of blood vessels(57).
In addition to effects on inflammation and immunity, dietary
garlic dramatically affects the cardiovascular system(58). For
example, garlic consumption by humans may diminish the
progression of CVD by decreasing the levels of LDL and
total cholesterol, while concomitantly raising HDL levels.
Consumption of garlic is also associated with the inhibition
of platelet aggregation and reduced systolic and diastolic
blood pressure. Recently, garlic was found to decrease two
other markers of CVD, homocysteine and C-reactive protein.
Interestingly, our present results identified ‘Cardiovascular
System Development and Function’ as the most significant
function in the category ‘Physiological System Development
and Function’ of PTSO/PTS-fed chickens. This finding may
extend the effects of garlic metabolites to poultry. However,
the underlying pathways associated with the cardiovascular
system in poultry still needs to be studied.
In conclusion, in vivo feeding of young broiler chickens
with PTSO/PTS compound, a garlic-derived extract, improved
resistance to experimental E. acervulina infection and induced
significant alterations of the transcriptome in chicken intestinal
lymphocytes involving immune- and cardiovascular-related
gene pathways and networks. These results suggest that diet-
ary immunomodulation by garlic-derived compounds may
represent a possible alternative to current drug-based strat-
egies for commercial poultry production.
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